Concerns on Medications Used in Osteoporosis
Osteoporosis is a systemic skeletal disorder that affects bone microarchitecture resulting to fragility fractures. Randomized controlled trials have shown efficacy of antiresorptives and osteoanabolic agents in addressing concerns of osteoporosis especially in the older population. However, publishe...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
World Scientific Publishing
2022-06-01
|
| Series: | Journal of Clinical Rheumatology and Immunology |
| Subjects: | |
| Online Access: | https://www.worldscientific.com/doi/10.1142/S2661341722300063 |
| _version_ | 1811344021722759168 |
|---|---|
| author | Julie Li-Yu |
| author_facet | Julie Li-Yu |
| author_sort | Julie Li-Yu |
| collection | DOAJ |
| description | Osteoporosis is a systemic skeletal disorder that affects bone microarchitecture resulting to fragility fractures. Randomized controlled trials have shown efficacy of antiresorptives and osteoanabolic agents in addressing concerns of osteoporosis especially in the older population. However, published guidance from several organizations started to focus as well on the perceived harms most especially of bisphosphonates considering their persistent effect on the bones. Similar to other chronic diseases, decision on whether or not to continue therapy depends on factors that might persistently provide signal on the individual’s further risk of unwanted but preventable outcomes. |
| first_indexed | 2024-04-13T19:40:18Z |
| format | Article |
| id | doaj.art-acf5d196d87c4391a6c6703f7a3743d1 |
| institution | Directory Open Access Journal |
| issn | 2661-3417 2661-3425 |
| language | English |
| last_indexed | 2024-04-13T19:40:18Z |
| publishDate | 2022-06-01 |
| publisher | World Scientific Publishing |
| record_format | Article |
| series | Journal of Clinical Rheumatology and Immunology |
| spelling | doaj.art-acf5d196d87c4391a6c6703f7a3743d12022-12-22T02:32:55ZengWorld Scientific PublishingJournal of Clinical Rheumatology and Immunology2661-34172661-34252022-06-0122Supp01202810.1142/S2661341722300063Concerns on Medications Used in OsteoporosisJulie Li-Yu0Chief Section of Rheumatology, Faculty of Medicine and Surgery, University of Santo Tomas, Manila, NCR, PhilippinesOsteoporosis is a systemic skeletal disorder that affects bone microarchitecture resulting to fragility fractures. Randomized controlled trials have shown efficacy of antiresorptives and osteoanabolic agents in addressing concerns of osteoporosis especially in the older population. However, published guidance from several organizations started to focus as well on the perceived harms most especially of bisphosphonates considering their persistent effect on the bones. Similar to other chronic diseases, decision on whether or not to continue therapy depends on factors that might persistently provide signal on the individual’s further risk of unwanted but preventable outcomes.https://www.worldscientific.com/doi/10.1142/S2661341722300063ConcernsMedicationsOsteoporosis |
| spellingShingle | Julie Li-Yu Concerns on Medications Used in Osteoporosis Journal of Clinical Rheumatology and Immunology Concerns Medications Osteoporosis |
| title | Concerns on Medications Used in Osteoporosis |
| title_full | Concerns on Medications Used in Osteoporosis |
| title_fullStr | Concerns on Medications Used in Osteoporosis |
| title_full_unstemmed | Concerns on Medications Used in Osteoporosis |
| title_short | Concerns on Medications Used in Osteoporosis |
| title_sort | concerns on medications used in osteoporosis |
| topic | Concerns Medications Osteoporosis |
| url | https://www.worldscientific.com/doi/10.1142/S2661341722300063 |
| work_keys_str_mv | AT julieliyu concernsonmedicationsusedinosteoporosis |